Search research articles
Contact Us
Filters
Showing results (61-70 of 244) with videos related to
Page
of 25
Sort By:
Journal of the National Cancer Institute
|
August 18, 2022
Social Vulnerability and Risk of Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation
Rusha Bhandari, Jennifer Berano Teh, Tianhui He, et al.
Blood
|
August 15, 2002
HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome
Yogen Saunthararajah, Ryotaro Nakamura, Jun-Mo Nam, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 2, 2019
Post-Allogeneic Hematopoietic Stem Cell Transplantation Eculizumab as Prophylaxis Against Hemolysis and Thrombosis for Patients with Hematologic Disorders Associated with Paroxysmal Nocturnal Hemoglobinuria Clones
Matthew Mei, Rohan Gupta, Margaret O'Donnell, et al.
Transplantation
|
August 27, 2019
Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Unrelated Donor Using Tacrolimus/Sirolimus-based GvHD Prophylaxis: Impact of HLA Mismatch
Monzr M Al Malki, Ketevan Gendzekhadze, Dongyun Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 8, 2021
Atrial Fibrillation in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Ellen K Chang, Dayana Chanson, Jennifer Berano Teh, et al.
Stem Cell Research & Therapy
|
April 19, 2023
The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective study
Dat Ngo, Jason Chen, Jose Tinajero, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 13, 2006
Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma
Roberto Rodriguez, Auayporn Nademanee, Nora Ruel, et al.
Blood
|
July 13, 2013
Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS)
Wael Saber, Corey S Cutler, Ryotaro Nakamura, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 28, 2014
Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network #1102 study rationale, design, and methods
Wael Saber, Jennifer Le Rademacher, Mikkael Sekeres, et al.
BMC Cancer
|
May 1, 2023
Feasibility of implementing a supervised telehealth exercise intervention in frail survivors of hematopoietic cell transplantation: a pilot randomized trial
Kyuwan Lee, Justin Shamunee, Lanie Lindenfeld, et al.
Page
of 25
Search research articles
Search
Showing results (61-70 of 244) with videos related to
Sort By:
Page
of 25
Journal of the National Cancer Institute
|
August 18, 2022
Social Vulnerability and Risk of Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation
Rusha Bhandari, Jennifer Berano Teh, Tianhui He, et al.
Blood
|
August 15, 2002
HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome
Yogen Saunthararajah, Ryotaro Nakamura, Jun-Mo Nam, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 2, 2019
Post-Allogeneic Hematopoietic Stem Cell Transplantation Eculizumab as Prophylaxis Against Hemolysis and Thrombosis for Patients with Hematologic Disorders Associated with Paroxysmal Nocturnal Hemoglobinuria Clones
Matthew Mei, Rohan Gupta, Margaret O'Donnell, et al.
Transplantation
|
August 27, 2019
Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Unrelated Donor Using Tacrolimus/Sirolimus-based GvHD Prophylaxis: Impact of HLA Mismatch
Monzr M Al Malki, Ketevan Gendzekhadze, Dongyun Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 8, 2021
Atrial Fibrillation in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Ellen K Chang, Dayana Chanson, Jennifer Berano Teh, et al.
Stem Cell Research & Therapy
|
April 19, 2023
The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective study
Dat Ngo, Jason Chen, Jose Tinajero, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 13, 2006
Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma
Roberto Rodriguez, Auayporn Nademanee, Nora Ruel, et al.
Blood
|
July 13, 2013
Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS)
Wael Saber, Corey S Cutler, Ryotaro Nakamura, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 28, 2014
Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network #1102 study rationale, design, and methods
Wael Saber, Jennifer Le Rademacher, Mikkael Sekeres, et al.
BMC Cancer
|
May 1, 2023
Feasibility of implementing a supervised telehealth exercise intervention in frail survivors of hematopoietic cell transplantation: a pilot randomized trial
Kyuwan Lee, Justin Shamunee, Lanie Lindenfeld, et al.
Page
of 25